Samanta Romina Zanetti

6PUBLICATIONS
76CO-AUTHORS
Autonomic nervous systemHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 22, 2025
NEDDylation Regulates CD8+ T-cell Metabolism and Antitumor Immunity.

Borja Jiménez-Lasheras, Paloma Velasco-Beltrán, Leire Egia-Mendikute

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Apr 14, 2022
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.

Clara Bueno, Susana Barrera, Alex Bataller

|Apr 01, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno

|Sep 02, 2020
Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

Samanta Romina Zanetti, Paola Alejandra Romecin, Meritxell Vinyoles

|Aug 14, 2020
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope.

Talia Velasco-Hernandez, Samanta Romina Zanetti, Heleia Roca-Ho

Pageof 1

Frequent Collaborators

3 joint publications

Manel Juan

2 joint publications

Talia Velasco-Hernandez

2 joint publications

Josep-Maria Ribera

2 joint publications

Valentín Ortiz-Maldonado